Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn’s Disease.

Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn’s Disease.

Inflamm Bowel Dis. 2019 Nov 07;:

Authors: Chiba M, Tsuji T, Nakane K, Obara Y, Komatsu M

PMID: 31697829 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31697829?dopt=Abstract